Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Malignant hyperthermia and ECT.

O F Yacoub, D H Morrow

The American Journal of Psychiatry

|August 1, 1986

Summary

This summary is machine-generated.

Malignant hyperthermia is a rare drug reaction. Awareness and preparedness are crucial when using succinylcholine for muscle relaxation before electroconvulsive therapy (ECT).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Quality improvement and substance abuse: rethinking impaired provider policies.

American journal of medical quality : the official journal of the American College of Medical Quality·1996

Same author

A reevaluation of the association between instrument delivery and epidural analgesia.

Regional anesthesia·1995

Same author

Post-caesarean section analgesia: a comparison of epidural butorphanol and morphine.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·1991

Same author

Vecuronium for rapid-sequence intubation for cesarean section.

Anesthesia and analgesia·1990

Same author

Monitoring of axillary arterial pressure in a patient with Buerger's disease requiring clipping of an intracerebral aneurysm.

British journal of anaesthesia·1987

Same author

Determination of hydralazine in human plasma by high-performance liquid chromatography with electrochemical detection.

Journal of chromatography·1987

Same journal

2026 Annual Meeting: President-Elect Address.

The American journal of psychiatry·2026

Same journal

2026 Annual Meeting: CEO and Medical Director's Address.

The American journal of psychiatry·2026

Same journal

Reports to the Membership.

The American journal of psychiatry·2026

Same journal

Convergent Metabolic Dysregulations But Divergent Contributing Pathways Across Severe Mental Disorders: The Power of Combining Genetics and Metabolomics.

The American journal of psychiatry·2026

Same journal

2026 Annual Meeting: Presidential Address.

The American journal of psychiatry·2026

Same journal

Represcribing Previously Used Antipsychotics: Response to So.

The American journal of psychiatry·2026

See all related articles

Area of Science:

Anesthesiology
Neurology
Pharmacology

Background:

Malignant hyperthermia is a rare, life-threatening hypermetabolic state.
It is triggered by specific drugs, primarily anesthetics and succinylcholine.
Succinylcholine is commonly used for muscle relaxation during electroconvulsive therapy (ECT).

Purpose of the Study:

To review the current understanding of malignant hyperthermia.
To outline management strategies for malignant hyperthermia in the context of ECT.
To inform healthcare providers about the risks and treatment of malignant hyperthermia during ECT.

Main Methods:

Literature review on malignant hyperthermia.
Analysis of succinylcholine use in ECT procedures.

Related Experiment Videos

Development of a proposed course of action for managing malignant hyperthermia.

Main Results:

Malignant hyperthermia is a significant risk associated with succinylcholine use in ECT.
Familiarity with the syndrome and its treatment is essential for safe ECT administration.
A structured approach is needed for patients undergoing ECT with known susceptibility.

Conclusions:

Healthcare providers must be aware of malignant hyperthermia risks during ECT.
Prompt recognition and treatment of malignant hyperthermia are critical.
Protocols for managing malignant hyperthermia in ECT patients are necessary.